Alzheimers disease (AD) is the most common type of dementia
IN THIS EPISODE - What a peptide actually is, and why your GLP-1 is NOT the same thing as BPC-157 or TB-500 - The seven peptides the FDA is reviewing: BPC-157, KPV, TB-500 (the "Wolverine complex"), MOTS-c, DSIP, Semax, and Epitalon - The "funding gap" why peptides that can't be patented never get human clinical trials - Six things the FDA worries about in an unlabeled vial, from identity and purity to the cancer/angiogenesis risk - The two questions that tell you if a peptide provider is legitimate (503A/B pharmacies and third-party certificates of analysis) ABOUT THE GUEST Tanna Donalson is a Physician Assistant and Owner of Redbud Medical in Denver Colorado
This cellular process contributes to structural muscle adaptation in controlled experimental settings
Many individuals come to us feeling discouraged after years of trying different diets without lasting success
For ConsumerLab's most recent tests of meal replacement shakes, drinks and mixes, please see our Protein Powders, Shakes, and Meal Replacements Review
